Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biomanufacturing Facility
Sort By
Newest First
1 / 1
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01
Nov 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01
Oct 05, 2023
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
Samsung Biologics
PR-M03-23-05
Mar 17, 2023
Biomanufacturing Facility
OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility
OmniaBio
PR-M10-22-05
Oct 06, 2022
Pharma 4.0
Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future
Yuk Chun Chiu, M.S.E.; Dawn Wofford; Patricia Robbins; Yvonne Duckworth; Steve Attig
Wheeler Bio
PAO-06-022-CL-11
Sep 08, 2022
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
Scorpius BioManufacturing
PR-M04-22-12
Apr 26, 2022
New Biodefense Facility
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
Heat Biologics
PR-M04-22-10
Apr 18, 2022
Expansion
New Facilities Help AGC Biologics Discover What's Possible
Patricio E. Massera
AGC Biologics
PAO-03-22-R250-16
Mar 19, 2022
Recombinant Proteins
Meeting the Renewed Demand for Microbial Protein Production
Grifols Recombinant Protein CDMO
PAO-01-22-R250-07
Jan 28, 2022
Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
Evotec
PR-M04-21-020
Apr 20, 2021
Biomanufacturing Facility
LakePharma Announces its cGMP MicroBiomanufacturing Center is Now Operational
LakePharma
PR-M12-18-NI-073
Dec 21, 2018
Investment
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
WuXi Biologics
PR-M05-18-NI-011
May 03, 2018
1 / 1
